Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients

European Respiratory Journal, Supplement

Volumn 20, Issue 36, 2002, Pages

  Mayaud, Charles ^a   Parrot, A ^a   Cadranel, J ^a  

^a HÔPITAL TENON   (France)

Author keywords

Acquired immune deficiency syndrome; Bacterial bronchitis; Bacterial pneumonia; Human immunodeficiency virus infection; Prophylaxis

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; PNEUMOCOCCUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; LYMPHOCYTE COUNT; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE; AIDS RELATED COMPLEX; BACTERIAL INFECTION; HOSPITALIZATION; IMMUNOLOGY; RESPIRATORY TRACT INFECTION; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL INFECTIONS; HIV INFECTIONS; HUMANS; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 0036633530     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (138)

1. Pulmonary complications of the acquired immunodeficiency syndrome
2. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome
3. Pulmonary infectious complications of human immunodeficiency virus infection (part I)
4. New developments in the pulmonary diseases affecting HIV-infected patients
5. Pulmonary infections in HIV-1 infected patients
6. Aids and the lung in a changing world
7. Respiratory disease trends in the pulmonary complications of HIV-infection study cohort
8. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug-users
9. Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: Incidence, etiologies, and clinical aspects
10. Invasive pneumococcal disease in a cohort of predominantly HIV1-infected female sex workers in Nairobi
11. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi
12. Pulmonary complications of HIV infection in Dar es Salaam, Tanzania
13. Aetiology, outcome and risk factors for mortality among adults with acute pneumonia in Kenya
14. Respiratory illness in persons with human immunodeficiency virus infection
15. Bacterial pneumonia in persons infected with the human immunodeficiency virus
16. Bacterial pneumonia in HIV-infected patients: Analysis of risk factors and prognostic indicators
17. Neutropenia and bacterial infection in acquired immunodeficiency syndrome
18. Splenectomy in patients with AIDS and AIDS-related complex
19. Severe pneumococcal infections in splenectomized HIV-positive patients
20. Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: Incidence, risk factors and outcome
21. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children
22. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome
23. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome
24. Bronchopneumopathies bactériennes chez les malades atteints de syndrome d'immunodépression acquise
25. Bacteremial infections in adults patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex
26. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population
27. Invasive pneumococcal disease: Clinical features, serotypes and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency infection
28. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: Findings of a French survey
29. Invasive pneumococcal infections in human immunodeficiency virus-infected children
30. Bacterial pneumonia in hospitalized patients with HIV infection
31. Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients
32. Legionnaires' disease in human immunodeficiency virus-infected patients: Eight cases and review
33. Chlamydia pneumoniae pneumonia in hospitalized patients
34. The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus
35. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection
36. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected patients: A clinical, radiological, microbiological, and epidemiological study
37. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus. A case-control study
38. Pseudomonas aeruginosa bacteria in patients with AIDS
39. Pseudomonas aeruginosa bronchopulmonary infection in patients with AIDS, with emphasis on relapsing infection
40. Actinomycetales infection in the acquired immunodeficiency syndrome
41. Pulmonary nocardiosis in the acquired immunodeficiency syndrome
42. Nocardiose pulmonaire et cérébrale chez un patient infecté par le VIH
43. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: Clinical features and outcome
44. Lung abscess due to Corynebacterium equi
45. Rhodococcus equi infections of humans
46. Rhodococcus equi infection in HIV-infected patients
47. Rhodococcus equi infections: Antibiotic therapy and relapses
48. Streptomyces pneumonia in a patient with human immunodeficiency virus infection: Case report and review of the literature in invasive Streptomyces infections
49. Pasteurella multocida pneumonia in a man with AIDS and nontraumatic feline exposure
50. Bordetella bronchiseptica pneumonia in a patient with AIDS
51. Sinusite et pneumopathie à Bordetella bronchiseptica au cours du SIDA
52. Neisseria spp and AIDS
53. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus
54. Corynebacterium pseudodiphtheriticum pulmonary infection in AIDS patients
55. Legionella bozemanii pneumonia in three patients with AIDS
56. Salmonella lung involvement in patients with HIV infection
57. Focal infections due to non-typhi Salmonella in patients with AIDS: Report of 10 cases and review
58. Clinical predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients
59. Fréquence respective et aspects radiocliniques de 150 pneumopathies observées chez 125 malades infectés par le virus de l'immunodéficience humaine
60. Radiographic manifestations of pulmonary disease in the acquired immunodeficiency syndrome (AIDS)
61. Pulmonary and mediastinal involvement in AIDS
62. Utility of lactate deshydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia
63. Bacteremia with Streptococcus pneumoniae
64. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
65. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: Clinical presentation, bacteriology and outcome
66. Community acquired lobar pneumonia in patients with HIV-infection and AIDS
67. Parapneumonic effusions secondary to community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients
68. Pneumopathies dues à Streptococcus pneumoniae chez 27 malades infectés par le VIH
69. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients
70. Pleural effusion and pneumothorax in hospitalized patients with HIV infection
71. Respiratory involvements during HIV infection: A diagnostic and therapeutic strategy
72. Diagnosis of pulmonary disease in acquired immune deficiency syndrome
73. Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients
74. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients
75. Lung abscess in patients with AIDS
76. Transthoracic needle aspirations in the study of pulmonary infections in patients with HIV
77. Site-directed bronchoalveolar lavage and transbronchial biopsy in HIV-infected patients with pneumonia
78. Pneumococcal bacteremia with pneumonia
79. Characterization of Streptococcus pneumoniae from human immunodeficiency virus-seropositive patients with acute and recurrent pneumonia
80. Bronchiectasis in pediatric AIDS
81. Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression
82. Do bacterial pneumonia and Pneumocystis carinii pneumonia accelerate progression of human immunodeficiency virus disease?
83. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1
84. In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+T cells after bacterial stimulation
85. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia
86. Permanent decline in pulmonary function following pneumonia in human immunodeficiency virus-infected persons
87. HIV-1 and the lung
88. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome
89. Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome
90. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome
91. Streptococcus pneumoniae colonization, bacteremia and immune response among persons with human immunodeficiency virus infection
92. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals
93. BAL and serum IgG levels in healthy asymptomatic HIV-infected patients
94. Impairment of neutrophil bactericidal capacity in patients with AIDS
95. Functionally relevant changes occur in HIV-infected individuals' alveolar macrophages prior to the onset of respiratory disease
96. Association of low mannose-binding lectin serum concentrations and bacterial pneumonia in HIV infection
97. Changing patterns of infections in patients with AIDS: A study of 279 autopsies of prison inmates and non incarcerated patients in a university hospital in Eastern Texas. 1984-1993
98. Causes of death in persons with human immunodeficiency virus infection
99. Pulmonary complications of HIV infection: Autopsy findings
100. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis
101. Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1
102. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
103. Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus
104. Prophylaxis of respiratory tract infection during HIV infection
105. 1999 USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
106. Response to pneumococcal vacccine among symptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with HIV
107. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes
108. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine
109. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjets: Persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response
110. Pneumonia in HIV-infected patients: A case-control survey of factors involved in risk and prevention
111. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
112. Pneumococcal disease among human immunodeficiency virus-infected persons: Incidence, risk factors, and impact of vaccination
113. 23-Valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults: Double-blind randomised and placebo controlled trial
114. Pneumococcal vaccination in HIV-1 infected adults in Uganda: Humoral response and two vaccine failures
115. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
116. The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients
117. Secondary Pneumocystis carinii pneumonia prophylaxis with trimethoprim-sulphamethoxazole does not prevent bacterial pneumonia in HIV-infected persons
118. Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia and death in persons with AIDS
119. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease
120. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: An evaluation of the provisional WHO/UNAIDS recommendations
121. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1 infected adults in Abidjan, Côte d'Ivoire: A randomised trial
122. Efficacy of trimethoprim-sulfamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Côte d'Ivoire: A randomised controlled trial
123. Emergence of trimethoprimsulfamethoxazole resistance in the AIDS era
124. Effect of prophylaxis on the clinical manifestations of AIDS-related opportunistic infections
125. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: Impact on risk for infectious diseases
126. + cell count
127. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection
128. Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
129. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy
130. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy
131. The impact of patient antiretroviral therapy in the characteristics of hospitalized patients with HIV infection
132. Changes in the pathological findings at autopsy in AIDS cases for the last 15 years
133. AIDS-related opportunistic illnesses occuring after initiation of potent antiretroviral therapy
134. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS
135. Acute respiratory failure following HAART introduction in patients treated for Pneumocystis carinii pneumonia
136. Epidemiology of Pneumocystis carinii pneumonia in an era of effective prophylaxis: The relative contribution of non-adherence and drug failure
137. Pre-AIDS mortality in HIV-infected individuals in England, Wales and Northern Ireland, 1982-1996